Technology · India
Danaher is a leading global life sciences and diagnostics innovator, helping to solve many of the world’s most important health challenges. Ultimately improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. What differentiates Danaher is not only what we do, but how we do it—accelerating the journey from idea to impact through a connected ecosystem of companies, deep scientific expertise, and a culture of continuous improvement powered by the Danaher Business System. Working as one Danaher, our businesses bring the right combination of technologies, scale and partnership to solve the hardest problems—and help customers move from discovery to delivery faster. Danaher is a science and technology leader with biotech, diagnostics, and life sciences businesses innovating at the speed of life . Throughout the years, Danaher established leadership positions in the science and technology sectors that define it today. Danaher is established in 1984 by brothers Steven Rales and Mitchell Rales who envision a new kind of company – one dedicated to continuous improvement and customer satisfaction. In 1988, Danaher develops the Danaher Business System (DBS) which drives growth and efficiency across Danaher and its operating companies and continues as a critical part of Danaher’s success today. Through a combination of strategic M&A and DBS-driven operational and financial moves, Danaher grows from a small industrial company into a leading global multi-industrial business. Danaher organizes its businesses around strategic platforms with sustainable competitive advantages in sizeable global markets and begins the journey toward who we are today . Danaher makes its strategic foray into the high-growth healthcare market with the 2004 acquisition of its first diagnostics business, Radiometer . Danaher gains a foothold in life sciences with the 2010 acquisition of SCIEX and expands its diagnostics portfolio with the 2011 acquisition of Beckman Coulter Diagnostics . In a strategic reorganization, Danaher spins off its industrial and dental businesses into Fortive (2016) and Envista (2019), respectively, sharpening its focus on life sciences and diagnostics . Acquiring brands such as Pall , Cepheid , and Integrated DNA Technologies , establishes Danaher as a leading player in the bioprocessing, molecular diagnostics and genomic medicine markets. Complementing its biologic workflow solutions, Danaher acquires Cytiva , gaining highly innovative end-to-end bioprocessing solutions that help enable breakthrou
Danaher is a leading global life sciences and diagnostics innovator, helping to solve many of the world’s most important health challenges. Ultimately improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. What differentiates Danaher is not only what we do, but how we do it—accelerating the journey from idea to impact through a connected ecosystem of companies, deep scientific expertise, and a culture of continuous improvement powered by the Danaher Business System. Working as one Danaher, our businesses bring the right combination of technologies, scale and partnership to solve the hardest problems—and help customers move from discovery to delivery faster. Danaher is a science and technology leader with biotech, diagnostics, and life sciences businesses innovating at the speed of life . Throughout the years, Danaher established leadership positions in the science and technology sectors that define it today. Danaher is established in 1984 by brothers Steven Rales and Mitchell Rales who envision a new kind of company – one dedicated to continuous improvement and customer satisfaction. In 1988, Danaher develops the Danaher Business System (DBS) which drives growth and efficiency across Danaher and its operating companies and continues as a critical part of Danaher’s success today. Through a combination of strategic M&A and DBS-driven operational and financial moves, Danaher grows from a small industrial company into a leading global multi-industrial business. Danaher organizes its businesses around strategic platforms with sustainable competitive advantages in sizeable global markets and begins the journey toward who we are today . Danaher makes its strategic foray into the high-growth healthcare market with the 2004 acquisition of its first diagnostics business, Radiometer . Danaher gains a foothold in life sciences with the 2010 acquisition of SCIEX and expands its diagnostics portfolio with the 2011 acquisition of Beckman Coulter Diagnostics . In a strategic reorganization, Danaher spins off its industrial and dental businesses into Fortive (2016) and Envista (2019), respectively, sharpening its focus on life sciences and diagnostics . Acquiring brands such as Pall , Cepheid , and Integrated DNA Technologies , establishes Danaher as a leading player in the bioprocessing, molecular diagnostics and genomic medicine markets. Complementing its biologic workflow solutions, Danaher acquires Cytiva , gaining highly innovative end-to-end bioprocessing solutions that help enable breakthrou
2–3 DSA coding problems on HackerRank, CodeSignal, or company platform
Data structures & algorithms — arrays, trees, graphs, dynamic programming
System design or low-level design — scalability, APIs, databases
Career goals, teamwork, strengths/weaknesses, role expectations